Logo image of DTEA

DAVIDSTEA INC (DTEA) Stock Fundamental Analysis

NASDAQ:DTEA - Nasdaq - CA2386611024 - Common Stock - Currency: USD

0.52  -0.01 (-1.89%)

After market: 0.4699 -0.05 (-9.63%)

Fundamental Rating

2

Taking everything into account, DTEA scores 2 out of 10 in our fundamental rating. DTEA was compared to 121 industry peers in the Specialty Retail industry. The financial health of DTEA is average, but there are quite some concerns on its profitability. DTEA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DTEA had negative earnings in the past year.
In the past year DTEA had a positive cash flow from operations.
DTEA had negative earnings in 4 of the past 5 years.
In multiple years DTEA reported negative operating cash flow during the last 5 years.
DTEA Yearly Net Income VS EBIT VS OCF VS FCFDTEA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M -100M

1.2 Ratios

The profitability ratios for DTEA are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DTEA Yearly ROA, ROE, ROICDTEA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 100 -100

1.3 Margins

DTEA has a better Gross Margin (40.93%) than 64.75% of its industry peers.
In the last couple of years the Gross Margin of DTEA has declined.
DTEA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y-3.74%
DTEA Yearly Profit, Operating, Gross MarginsDTEA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50

More info and screens

5

2. Health

2.1 Basic Checks

DTEA does not have a ROIC to compare to the WACC, probably because it is not profitable.
DTEA has more shares outstanding than it did 1 year ago.
DTEA has a worse debt/assets ratio than last year.
DTEA Yearly Shares OutstandingDTEA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
DTEA Yearly Total Debt VS Total AssetsDTEA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

DTEA has an Altman-Z score of 0.14. This is a bad value and indicates that DTEA is not financially healthy and even has some risk of bankruptcy.
DTEA has a Altman-Z score of 0.14. This is amonst the worse of the industry: DTEA underperforms 82.73% of its industry peers.
DTEA has a debt to FCF ratio of 2.05. This is a good value and a sign of high solvency as DTEA would need 2.05 years to pay back of all of its debts.
DTEA's Debt to FCF ratio of 2.05 is amongst the best of the industry. DTEA outperforms 84.89% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that DTEA is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.22, DTEA is doing good in the industry, outperforming 66.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 2.05
Altman-Z 0.14
ROIC/WACCN/A
WACC10.2%
DTEA Yearly LT Debt VS Equity VS FCFDTEA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.50 indicates that DTEA has no problem at all paying its short term obligations.
DTEA has a better Current ratio (2.50) than 87.77% of its industry peers.
A Quick Ratio of 1.17 indicates that DTEA should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.17, DTEA is doing good in the industry, outperforming 75.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 1.17
DTEA Yearly Current Assets VS Current LiabilitesDTEA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for DTEA have decreased strongly by -122.35% in the last year.
The Revenue for DTEA has decreased by -12.14% in the past year. This is quite bad
DTEA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -13.59% yearly.
EPS 1Y (TTM)-122.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-151.1%
Revenue 1Y (TTM)-12.14%
Revenue growth 3Y-21.21%
Revenue growth 5Y-13.59%
Sales Q2Q%-27.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DTEA Yearly Revenue VS EstimatesDTEA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
DTEA Yearly EPS VS EstimatesDTEA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 0 0.1 -0.1 0.2 0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

DTEA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DTEA Price Earnings VS Forward Price EarningsDTEA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, DTEA is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.55
EV/EBITDA N/A
DTEA Per share dataDTEA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DTEA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DAVIDSTEA INC

NASDAQ:DTEA (4/14/2023, 8:00:00 PM)

After market: 0.4699 -0.05 (-9.63%)

0.52

-0.01 (-1.89%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)04-27 2023-04-27
Inst Owners0.01%
Inst Owner Change-71.84%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.84M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF 3.55
P/OCF 3.47
P/B 0.5
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY28.14%
OCF(TTM)0.15
OCFY28.82%
SpS2.55
BVpS1.05
TBVpS1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.93%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y-3.74%
F-Score2
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 2.05
Debt/EBITDA N/A
Cap/Depr 3.25%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.5
Quick Ratio 1.17
Altman-Z 0.14
F-Score2
WACC10.2%
ROIC/WACCN/A
Cap/Depr(3y)10.69%
Cap/Depr(5y)52.02%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-151.1%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.14%
Revenue growth 3Y-21.21%
Revenue growth 5Y-13.59%
Sales Q2Q%-27.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-559.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.45%
OCF growth 3YN/A
OCF growth 5YN/A